0001865257-23-000001.txt : 20230210 0001865257-23-000001.hdr.sgml : 20230210 20230210090932 ACCESSION NUMBER: 0001865257-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230210 DATE AS OF CHANGE: 20230210 EFFECTIVENESS DATE: 20230210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allyx Therapeutics, Inc. CENTRAL INDEX KEY: 0001865257 IRS NUMBER: 832648948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-473164 FILM NUMBER: 23608807 BUSINESS ADDRESS: STREET 1: 470 JAMES STREET STREET 2: SUITE 007 CITY: NEW HAVEN STATE: CT ZIP: 06513 BUSINESS PHONE: 2038550400 MAIL ADDRESS: STREET 1: 470 JAMES STREET STREET 2: SUITE 007 CITY: NEW HAVEN STATE: CT ZIP: 06513 D 1 primary_doc.xml X0708 D LIVE 0001865257 Allyx Therapeutics, Inc. 470 JAMES STREET SUITE 007 NEW HAVEN CT CONNECTICUT 06513 2038550400 DELAWARE None None Corporation true 2018 Stephen Bloch 470 James Street Suite 007 New Haven CT CONNECTICUT 06513 Executive Officer Director Stephen Strittmatter 35R Catherine Drive Durham CT CONNECTICUT 06422 Director Robert A. Bettigole 33 Whitney Avenue New Haven CT CONNECTICUT 06510 Director Gregory P. Ho 650 Madison Avenue 20th Floor New York NY NEW YORK 10022 Director Paul Fonteyne 4 Deepwood Lane Westport CT CONNECTICUT 06880 Director Timothy Siegert 45 Eastland Road Hamden CT CONNECTICUT 06517 Executive Officer Biotechnology Decline to Disclose 06b false 2023-02-03 false true false 0 2308569 2308569 0 false 11 0 0 0 No amounts other than ordinary course employment compensation is being paid to officers and directors. false Allyx Therapeutics, Inc. Dr. Stephen Bloch Dr. Stephen Bloch Chief Executive Officer 2023-02-09